Long-term antibody response to inactivated SARS-CoV-2 vaccination in patients with chronic liver disease: A multicenter study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term antibody response to inactivated SARS-CoV-2 vaccination in patients with chronic liver disease: A multicenter study

Published:2023-08 Issue:7 Volume:47 Page:102150
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Yang Yinuo,Li Xuemei,Zhao Xinya,Liu Yiqing,Zhao Tong,Zhu Qiang^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference8 articles.

1. Outcomes of SARS-CoV-2 infection in patients with chronic liver disease and cirrhosis: a national COVID cohort collaborative study;Ge;Gastroenterology,2021

2. COVID-19 and liver disease: mechanistic and clinical perspectives;Marjot;Nat Rev Gastroenterol Hepatol,2021

3. Safety and immunogenicity of SARS-CoV-2 vaccines in patients with chronic liver diseases (CHESS-NMCID 2101): a multicenter study;Ai;Clin Gastroenterol Hepatol,2022

4. Antibody response 6 months after the booster dose of Pfizer in previous recipients of CoronaVac;Silva;J Med Virol,2022

5. Does the functional liver imaging score derived from gadoxetic acid-enhanced MRI predict outcomes in chronic liver disease?;Bastati;Radiology,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP